![Mitchell Krucoff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mitchell Krucoff
Corporate Officer/Principal bei CorAssist Cardiovascular Ltd.
Aktive Positionen von Mitchell Krucoff
Unternehmen | Position | Beginn |
---|---|---|
CorAssist Cardiovascular Ltd.
![]() CorAssist Cardiovascular Ltd. Medical SpecialtiesHealth Technology CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel. | Corporate Officer/Principal | - |
QRS Diagnostic LLC
![]() QRS Diagnostic LLC Medical SpecialtiesHealth Technology QRS Diagnostic LLC manufactures PC card medical diagnostic devices and stand alone spirometers. The firm designs and develops software-based medical devices. The company was founded by Patrick Lichter in 1995 and is headquartered in Plymouth, MN. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
QRS Diagnostic LLC
![]() QRS Diagnostic LLC Medical SpecialtiesHealth Technology QRS Diagnostic LLC manufactures PC card medical diagnostic devices and stand alone spirometers. The firm designs and develops software-based medical devices. The company was founded by Patrick Lichter in 1995 and is headquartered in Plymouth, MN. | Health Technology |
CorAssist Cardiovascular Ltd.
![]() CorAssist Cardiovascular Ltd. Medical SpecialtiesHealth Technology CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel. | Health Technology |